Structure |
Chemical Name |
CAS |
MF |
 |
(R)-3-((R)-5-(4-fluorophenyl)-5-hydroxypentanoyl)-4-phenyloxazolidin-2-one |
1612153-32-8 |
C20H20FNO4 |
 |
(S)-3-((R)-5-(4-fluorophenyl)-5-hydroxypentanoyl)-4-phenyloxazolidin-2-one |
528565-93-7 |
C20H20FNO4 |
 |
Posaconazole iMpurity 3 |
|
|
 |
Bezafibrate Impurity D |
41859-58-9 |
C21H24ClNO4 |
 |
Cloxacillin Sodium EP Impurity B (Mixture of Diastereomers) |
1642559-64-5 |
C18H20ClN3O4S |
![ethyl (4,6-diamino-2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b] pyridin-3-yl)pyrimidin-5-yl)(methyl)carbamate](/CAS/20180702/GIF/625115-53-9.gif) |
ethyl (4,6-diamino-2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b] pyridin-3-yl)pyrimidin-5-yl)(methyl)carbamate |
625115-53-9 |
C21H21FN8O2 |
![2-[(4-CHLORO-2-NITROPHENYL)AMINO]-BENZOIC ACID](/CAS/GIF/60091-87-4.gif) |
2-[(4-CHLORO-2-NITROPHENYL)AMINO]-BENZOIC ACID |
60091-87-4 |
C13H9ClN2O4 |
 |
Fulvestrant impurity I |
|
|
 |
Emtricitabine |
61548-81-0 |
C11H22O3S |
 |
tert-butyl 4-(3-nitropyridin-4-yl)piperazine-1-carboxylate |
608142-93-4 |
C14H20N4O4 |
![4-BROMO-1-(TOLUENE-4-SULFONYL)-1,2,3,4-TETRAHYDROBENZO[B]AZEPIN-5-ONE](/CAS/GIF/29489-04-1.gif) |
4-BROMO-1-(TOLUENE-4-SULFONYL)-1,2,3,4-TETRAHYDROBENZO[B]AZEPIN-5-ONE |
29489-04-1 |
C17H16BrNO3S |
![3-[4-[2-イソプロポキシエトキシ)メチル]フェノキシ]-1,2-プロパンジオール](/CAS/20180703/GIF/1797024-50-0.gif) |
3-[4-[2-イソプロポキシエトキシ)メチル]フェノキシ]-1,2-プロパンジオール |
1797024-50-0 |
C15H24O5 |
 |
Ceftriaxone Impurity |
79221-95-7 |
C18H18N8O8S3 |
 |
フェキソフェナジンメチルエステル |
154825-96-4 |
C33H41NO4 |
 |
Betaxolol EP Impurity E |
1329613-85-5 |
C18H31NO3 |
 |
Bendamustine Related Impurity 21 |
|
|
 |
Tulobuterol Impurity |
34356-83-7 |
C8H5Br2ClO |
 |
Bendamustine Related Impurity 8 |
|
|
 |
Bortezomib Impurity 33 |
|
|
 |
Moxifloxacin Impurity 31 |
|
|
 |
Pitavastatin Impurity 7 |
|
|
 |
Prednisolone Impurity A |
77017-17-5 |
C21H26O5 |
 |
Rivaroxaban Impurity 61 |
1643354-27-1 |
C32H30N4O8 |
 |
Rivaroxaban Impurity 74 |
|
|
 |
Sitafloxacin Impurity 6 |
|
|
 |
Ticagrelor Related Compound 75 |
|
|
 |
Ticagrelor Related Compound 93 |
2207528-55-8 |
C23H28F2N6O4S |
 |
Vonoprazan Impurity 24 |
1807642-41-6 |
C16H14FN3O2S |
 |
Vonoprazan Impurity 35 |
|
|
 |
Blonanserin Impurity L |
|
|
 |
Cefazolin USP Impurity E |
|
|
 |
Exemestane Impurity 5 |
|
|
 |
Olaparib Impurity A |
|
|
 |
Dapoxetine Impurity 2 |
|
|
 |
Voriconazole Impurity 5 |
|
|
 |
tetrahydrofuran-3-yl 2-cyclopentyl-2-hydroxy-2-phenylacetate |
1404453-75-3 |
C17H22O4 |
 |
Lamivudine impurity 5 |
|
|
 |
Clopidogrel Impurity 2 |
|
C15H14ClNO2S |
 |
Mirabegron Impurity 6 |
2762802-64-0 |
C10H11ClN4O3S2 |
 |
Pitavastatin Impurity 3 |
|
|
 |
Solifenacin EP Impurity D |
|
|
 |
Cephalexin Impurity 2 |
|
C16H17N3O4S |
 |
Cefuroxime Impurity 3 |
|
C16H16N4O8S |
 |
Vonoprazan Impurity 11 |
|
|
 |
Erlotinib Imp.14 |
|
|
 |
Sorafenib related compound 12 |
284461-74-1 |
C20H14ClF3N4O3 |
 |
(1R,3S)-Solifenacin Succinate |
774517-20-3 |
C23H26N2O2 |
 |
Dacpomycin Impurity 2 |
|
|
 |
Nicorandil Impurity 3 |
|
|
 |
Tacrolimus Impurity A |
|
|
![1H-Benz[de]isoquinolin-1-one,2-(3S)-1-azabicyclo[2.2.2]oct-3-yl-2,3,3a,4,5,6-hexahydro-,(3aR)-](/CAS/20180703/GIF/135729-73-6.gif) |
1H-Benz[de]isoquinolin-1-one,2-(3S)-1-azabicyclo[2.2.2]oct-3-yl-2,3,3a,4,5,6-hexahydro-,(3aR)- |
135729-73-6 |
C19H24N2O |
 |
Mirabegron Impurity 19 |
|
|
![9-[(Z)-1-プロペニル]-9H-プリン-6-アミン](/CAS/20180703/GIF/1464851-21-5.gif) |
9-[(Z)-1-プロペニル]-9H-プリン-6-アミン |
1464851-21-5 |
C8H9N5 |
 |
Moxifloxacin impurity (20) |
|
|
 |
Medetomidine Impurity 28 |
2240179-64-8 |
C23H28N2 |
 |
Peramivir Impurity 4 |
229615-12-7 |
C15H28N4O4 |
 |
Peramivir Impurity 9 |
|
|
 |
PidotimodImpurity T |
|
|
 |
(Z)-methyl 3-(hydroxy(phenyl)methylene)-2-oxoindoline-6-carboxylate |
2093243-16-2 |
C17H13NO4 |
 |
Lenvatinib Impurity 10 |
|
|
 |
Empagliflozin Impurity 79 |
|
|
 |
Empagliflozin Impurity 89 |
2452301-32-3 |
C23H25ClO7 |
 |
Levocarnitine Impurity F |
6490-19-3 |
C7H17ClN2O2 |
 |
4,4-dimethyl-2-(2-phenylpropan-2-yl)oxazo‐ line |
874895-87-1 |
C14H19NO |
 |
Formoterol Impurity 4 |
|
|
 |
Roxadustat-001 |
319-57-3 |
C8H5BF4N2O2 |
 |
Ornidazole Impurity 24 |
|
|
 |
Olanzapine impurity ANB |
|
|
 |
Pitavastatin Impurity 75 |
|
|
 |
(R)-2-(2-(tert-butoxy)-2-oxoethyl)pentanoic acid |
112106-16-8 |
C11H20O4 |
 |
Bazedoxifene impurity |
|
|
 |
Tamsulosin impurity |
|
C20H28N2O5S |
 |
Clarithromycin (9Z)-Oxime |
127253-05-8 |
C38H70N2O13 |
 |
N-Desmethyl Clarithromycin (9E)-Oxime |
127182-43-8 |
C37H68N2O13 |
 |
Labetalol EP impurity G |
|
|
 |
2-(2-NITROPHENYL)ETHANAMINE |
33100-15-1 |
C8H10N2O2 |
 |
CLOZAPINE-D3 |
1215691-72-7 |
C18H19ClN4 |
 |
Bendamustine Impurity 25 |
|
|
 |
Canagliflozin Impurity 25 |
|
|
 |
Edoxaban Impurity 41 |
1353893-25-0 |
C14H27N3O3 |
 |
Istradefylline Impurity 5 |
|
|
 |
Milrinone Impurity 10 |
|
|
 |
Olanzapine Impurity 3 |
|
C17H20N4S |
 |
Ticagrelor Related Compound 54 |
|
|
 |
Blonanserin Impurity N |
|
|
 |
Brexpiprazole Impurity N |
|
|
 |
Cefaclor Impurity 1 |
|
|
 |
Cefminox Sodium impurity 4 |
|
|
 |
Cefradine Impurity B |
|
|
 |
Dapoxetine Impurity F |
|
|
 |
Olaparib Impurity E |
|
|
 |
Cefathiamidine Impurity 6 |
28240-16-6 |
C12H13ClN2O6S |
![rac-2,2'-(((3aR,3a'R,4R,4'R,6S,6aS,6'S,6a'S)-((5-nitro-2-(propylthio)pyrimidine-4,6-diyl)bis(azanediyl))bis(2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxole-6,4-diyl))bis(oxy))bis(ethan-1-ol)](/CAS/20211123/GIF/1882095-50-2.gif) |
rac-2,2'-(((3aR,3a'R,4R,4'R,6S,6aS,6'S,6a'S)-((5-nitro-2-(propylthio)pyrimidine-4,6-diyl)bis(azanediyl))bis(2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxole-6,4-diyl))bis(oxy))bis(ethan-1-ol) |
1882095-50-2 |
C27H43N5O10S |
 |
Imatinib impurity 31 |
1356565-47-3 |
C17H17N7 |
 |
LCZ696(valsartan + sacubitril) impurity 33 |
|
|
 |
Lenvatinib Impurity 26 |
|
|
 |
Ozagrel impurity C |
|
|
 |
Regorafenib Impurity 24 |
|
|
 |
Regorafenib Impurity 32 |
|
|
 |
Sitafloxacin Impurity ZZ-A-01 |
|
|